Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 12 March, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 530517 | NSE: RELAXO

Relaxo Footwears Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 8, 2025, 11:00 am

Market Cap 10,999 Cr.
Current Price 442
High / Low 950/408
Stock P/E62.7
Book Value 80.8
Dividend Yield0.68 %
ROCE13.9 %
ROE10.5 %
Face Value 1.00
PEG Ratio-6.48

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Relaxo Footwears Ltd

Competitors of Relaxo Footwears Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Campus Activewear Ltd 7,703 Cr. 252 372/21364.8 22.70.28 %16.7 %14.9 % 5.00
AKI India Ltd 79.4 Cr. 8.97 29.0/8.4056.3 7.260.00 %5.82 %3.65 % 2.00
Relaxo Footwears Ltd 10,999 Cr. 442 950/40862.7 80.80.68 %13.9 %10.5 % 1.00
Liberty Shoes Ltd 546 Cr. 321 570/24430.4 1260.00 %9.45 %7.21 % 10.0
Khadim India Ltd 543 Cr. 296 445/252104 1360.00 %7.80 %2.87 % 10.0
Industry Average7,128.00 Cr425.5060.4781.130.32%12.06%9.82%5.50

All Competitor Stocks of Relaxo Footwears Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 744698667670681765739715713747748679667
Expenses 622587581610609647631624626627649592584
Operating Profit 1221118659721181089287120998883
OPM % 16%16%13%9%11%15%15%13%12%16%13%13%12%
Other Income 56464471165577
Interest 4474444555555
Depreciation 29293031323335373838394040
Profit before tax 94845430418576605182605045
Tax % 25%25%28%26%26%26%26%27%24%25%26%26%26%
Net Profit 70633922306356443961443733
EPS in Rs 2.822.531.550.901.212.542.261.781.552.471.781.481.33

Last Updated: February 28, 2025, 5:30 pm

Below is a detailed analysis of the quarterly data for Relaxo Footwears Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is ₹667.00 Cr.. The value appears to be declining and may need further review. It has decreased from 679.00 Cr. (Sep 2024) to ₹667.00 Cr., marking a decrease of 12.00 Cr..
  • For Expenses, as of Dec 2024, the value is ₹584.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 592.00 Cr. (Sep 2024) to ₹584.00 Cr., marking a decrease of 8.00 Cr..
  • For Operating Profit, as of Dec 2024, the value is ₹83.00 Cr.. The value appears to be declining and may need further review. It has decreased from 88.00 Cr. (Sep 2024) to ₹83.00 Cr., marking a decrease of 5.00 Cr..
  • For OPM %, as of Dec 2024, the value is 12.00%. The value appears to be declining and may need further review. It has decreased from 13.00% (Sep 2024) to 12.00%, marking a decrease of 1.00%.
  • For Other Income, as of Dec 2024, the value is ₹7.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 7.00 Cr..
  • For Interest, as of Dec 2024, the value is ₹5.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 5.00 Cr..
  • For Depreciation, as of Dec 2024, the value is ₹40.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 40.00 Cr..
  • For Profit before tax, as of Dec 2024, the value is ₹45.00 Cr.. The value appears to be declining and may need further review. It has decreased from 50.00 Cr. (Sep 2024) to ₹45.00 Cr., marking a decrease of 5.00 Cr..
  • For Tax %, as of Dec 2024, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 26.00%.
  • For Net Profit, as of Dec 2024, the value is ₹33.00 Cr.. The value appears to be declining and may need further review. It has decreased from 37.00 Cr. (Sep 2024) to ₹33.00 Cr., marking a decrease of 4.00 Cr..
  • For EPS in Rs, as of Dec 2024, the value is 1.33. The value appears to be declining and may need further review. It has decreased from ₹1.48 (Sep 2024) to 1.33, marking a decrease of ₹0.15.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 3:02 pm

MetricMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 9811,1801,4411,6681,6311,9412,2922,4102,3592,6532,7832,9142,842
Expenses 8711,0321,2401,4271,4001,6391,9641,9981,8612,2352,4422,5032,451
Operating Profit 110148201241231302328413498418341411390
OPM % 11%13%14%14%14%16%14%17%21%16%12%14%14%
Other Income 12071441282223162624
Interest 182318231599191917222120
Depreciation 26314047515462109110114125147158
Profit before tax 6896143178178244268292391311210269237
Tax % 34%31%28%32%33%34%35%22%25%25%26%26%
Net Profit 4566103120120161175226292233154200176
EPS in Rs 1.872.744.295.014.996.697.079.1111.749.356.218.057.06
Dividend Payout % 5%5%6%6%10%11%13%14%21%27%40%37%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)46.67%56.06%16.50%0.00%34.17%8.70%29.14%29.20%-20.21%-33.91%29.87%
Change in YoY Net Profit Growth (%)0.00%9.39%-39.56%-16.50%34.17%-25.47%20.45%0.06%-49.41%-13.70%63.78%

Relaxo Footwears Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:9%
5 Years:5%
3 Years:7%
TTM:-3%
Compounded Profit Growth
10 Years:12%
5 Years:3%
3 Years:-11%
TTM:-13%
Stock Price CAGR
10 Years:9%
5 Years:-9%
3 Years:-29%
1 Year:-49%
Return on Equity
10 Years:16%
5 Years:14%
3 Years:11%
Last Year:10%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 7:46 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 66612121212252525252525
Reserves 2082713624685947491,0931,2481,5481,7351,8301,9761,986
Borrowings 225198239236178153112139144174164205212
Other Liabilities 147182234281286335394430459448476508500
Total Liabilities 5876578419971,0701,2501,6111,8412,1762,3832,4952,7142,722
Fixed Assets 3273664725315415258489819389871,1501,3711,364
CWIP 2424228621381146118149893346
Investments 00001100338194225108134
Other Assets 2362673674384665877528147821,0521,0301,2021,178
Total Assets 5876578419971,0701,2501,6111,8412,1762,3832,4952,7142,722

Below is a detailed analysis of the balance sheet data for Relaxo Footwears Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹25.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹1,986.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,976.00 Cr. (Mar 2024) to ₹1,986.00 Cr., marking an increase of 10.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹212.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹205.00 Cr. (Mar 2024) to ₹212.00 Cr., marking an increase of 7.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹500.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹508.00 Cr. (Mar 2024) to ₹500.00 Cr., marking a decrease of 8.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹2,722.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹2,714.00 Cr. (Mar 2024) to ₹2,722.00 Cr., marking an increase of 8.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹1,364.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹1,371.00 Cr. (Mar 2024) to ₹1,364.00 Cr., marking a decrease of 7.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹46.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹33.00 Cr. (Mar 2024) to ₹46.00 Cr., marking an increase of 13.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹134.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹108.00 Cr. (Mar 2024) to ₹134.00 Cr., marking an increase of 26.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹1,178.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹1,202.00 Cr. (Mar 2024) to ₹1,178.00 Cr., marking a decrease of 24.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹2,722.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹2,714.00 Cr. (Mar 2024) to ₹2,722.00 Cr., marking an increase of 8.00 Cr..

Notably, the Reserves (₹1,986.00 Cr.) exceed the Borrowings (212.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

No data available for this post.

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-115.00-50.00-38.005.0053.00149.00216.00274.00354.00244.00177.00206.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days132121242833352628343545
Inventory Days124109163147146130130157154202154179
Days Payable353961636372586581676976
Cash Conversion Cycle1029112310811090107119101170121148
Working Capital Days312031323243566049826475
ROCE %22%26%30%30%26%30%26%24%26%18%12%14%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Promoters70.92%70.78%70.78%70.78%70.78%71.02%71.25%71.27%71.27%71.27%71.27%71.27%
FIIs3.56%3.81%3.22%3.15%3.11%2.99%2.82%2.87%3.24%3.39%3.32%3.36%
DIIs7.17%7.08%6.94%7.07%7.43%7.64%7.96%8.34%8.53%8.86%9.33%9.54%
Public18.35%18.33%19.06%19.00%18.68%18.34%17.98%17.51%16.96%16.47%16.07%15.82%
No. of Shareholders2,23,3932,60,5623,10,0793,28,9693,45,7413,61,9273,58,7003,43,2953,16,1352,91,4012,69,3882,52,981

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
SBI Focused Equity Fund8,604,9162.03711.881,526,6882025-03-10463.63%
SBI Equity Hybrid Fund2,533,9880.29209.641,526,6882025-03-1065.98%
SBI Magnum Midcap Fund2,500,0001.02206.831,526,6882025-03-1063.75%
SBI Small Cap Fund1,800,0000.48148.911,526,6882025-03-1017.9%
SBI Multicap Fund1,621,7040.79134.161,526,6882025-03-106.22%
SBI Large & Midcap Fund1,550,0000.5128.231,526,6882025-03-101.53%
UTI Flexi Cap Fund1,526,6880.49126.31,526,6882025-03-100%
SBI Flexi Cap Fund1,347,0990.51111.451,526,6882025-03-10-11.76%
SBI Magnum Childrens Benefit Fund - Investment Plan400,0001.4233.091,526,6882025-03-10-73.8%
Sundaram Large and Mid Cap Fund348,3990.4228.821,526,6882025-03-10-77.18%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 8.056.219.3611.749.12
Diluted EPS (Rs.) 8.056.219.3511.749.12
Cash EPS (Rs.) 13.9811.2313.9116.1713.52
Book Value[Excl.RevalReserv]/Share (Rs.) 80.4074.5370.7263.3051.27
Book Value[Incl.RevalReserv]/Share (Rs.) 80.4074.5370.7263.3051.27
Dividend / Share (Rs.) 3.002.502.502.501.25
Revenue From Operations / Share (Rs.) 117.08111.80106.6094.9797.12
PBDIT / Share (Rs.) 17.4914.2417.6620.8616.84
PBIT / Share (Rs.) 11.579.2113.0916.4312.43
PBT / Share (Rs.) 10.828.4412.4815.7511.75
Net Profit / Share (Rs.) 8.056.219.3511.749.12
PBDIT Margin (%) 14.9412.7316.5621.9617.34
PBIT Margin (%) 9.888.2312.2817.3012.80
PBT Margin (%) 9.247.5411.7016.5812.10
Net Profit Margin (%) 6.875.558.7612.359.38
Return on Networth / Equity (%) 10.018.3213.2118.5417.78
Return on Capital Employeed (%) 13.1211.3216.9623.6421.61
Return On Assets (%) 7.386.199.7613.4012.28
Total Debt / Equity (X) 0.010.000.010.000.01
Asset Turnover Ratio (%) 1.121.141.161.171.40
Current Ratio (X) 2.402.542.572.401.91
Quick Ratio (X) 1.251.341.111.460.83
Inventory Turnover Ratio (X) 1.991.912.391.992.24
Dividend Payout Ratio (NP) (%) 31.0440.2826.690.0023.58
Dividend Payout Ratio (CP) (%) 17.8822.2517.930.0015.89
Earning Retention Ratio (%) 68.9659.7273.310.0076.42
Cash Earning Retention Ratio (%) 82.1277.7582.070.0084.11
Interest Coverage Ratio (X) 23.3018.4228.6730.3424.78
Interest Coverage Ratio (Post Tax) (X) 11.739.0316.1818.0714.41
Enterprise Value (Cr.) 20231.0821055.1126520.3321706.2014837.57
EV / Net Operating Revenue (X) 6.947.5710.009.206.16
EV / EBITDA (X) 46.4659.4260.3541.8835.50
MarketCap / Net Operating Revenue (X) 6.977.599.999.206.15
Retention Ratios (%) 68.9559.7173.300.0076.41
Price / BV (X) 10.1511.3915.0613.8111.65
Price / Net Operating Revenue (X) 6.977.599.999.206.15
EarningsYield 0.010.010.010.010.01

After reviewing the key financial ratios for Relaxo Footwears Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 8.05. This value is within the healthy range. It has increased from 6.21 (Mar 23) to 8.05, marking an increase of 1.84.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 8.05. This value is within the healthy range. It has increased from 6.21 (Mar 23) to 8.05, marking an increase of 1.84.
  • For Cash EPS (Rs.), as of Mar 24, the value is 13.98. This value is within the healthy range. It has increased from 11.23 (Mar 23) to 13.98, marking an increase of 2.75.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 80.40. It has increased from 74.53 (Mar 23) to 80.40, marking an increase of 5.87.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 80.40. It has increased from 74.53 (Mar 23) to 80.40, marking an increase of 5.87.
  • For Dividend / Share (Rs.), as of Mar 24, the value is 3.00. This value is within the healthy range. It has increased from 2.50 (Mar 23) to 3.00, marking an increase of 0.50.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 117.08. It has increased from 111.80 (Mar 23) to 117.08, marking an increase of 5.28.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 17.49. This value is within the healthy range. It has increased from 14.24 (Mar 23) to 17.49, marking an increase of 3.25.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 11.57. This value is within the healthy range. It has increased from 9.21 (Mar 23) to 11.57, marking an increase of 2.36.
  • For PBT / Share (Rs.), as of Mar 24, the value is 10.82. This value is within the healthy range. It has increased from 8.44 (Mar 23) to 10.82, marking an increase of 2.38.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 8.05. This value is within the healthy range. It has increased from 6.21 (Mar 23) to 8.05, marking an increase of 1.84.
  • For PBDIT Margin (%), as of Mar 24, the value is 14.94. This value is within the healthy range. It has increased from 12.73 (Mar 23) to 14.94, marking an increase of 2.21.
  • For PBIT Margin (%), as of Mar 24, the value is 9.88. This value is below the healthy minimum of 10. It has increased from 8.23 (Mar 23) to 9.88, marking an increase of 1.65.
  • For PBT Margin (%), as of Mar 24, the value is 9.24. This value is below the healthy minimum of 10. It has increased from 7.54 (Mar 23) to 9.24, marking an increase of 1.70.
  • For Net Profit Margin (%), as of Mar 24, the value is 6.87. This value is within the healthy range. It has increased from 5.55 (Mar 23) to 6.87, marking an increase of 1.32.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 10.01. This value is below the healthy minimum of 15. It has increased from 8.32 (Mar 23) to 10.01, marking an increase of 1.69.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 13.12. This value is within the healthy range. It has increased from 11.32 (Mar 23) to 13.12, marking an increase of 1.80.
  • For Return On Assets (%), as of Mar 24, the value is 7.38. This value is within the healthy range. It has increased from 6.19 (Mar 23) to 7.38, marking an increase of 1.19.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 0.01, marking an increase of 0.01.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 1.12. It has decreased from 1.14 (Mar 23) to 1.12, marking a decrease of 0.02.
  • For Current Ratio (X), as of Mar 24, the value is 2.40. This value is within the healthy range. It has decreased from 2.54 (Mar 23) to 2.40, marking a decrease of 0.14.
  • For Quick Ratio (X), as of Mar 24, the value is 1.25. This value is within the healthy range. It has decreased from 1.34 (Mar 23) to 1.25, marking a decrease of 0.09.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.99. This value is below the healthy minimum of 4. It has increased from 1.91 (Mar 23) to 1.99, marking an increase of 0.08.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 31.04. This value is within the healthy range. It has decreased from 40.28 (Mar 23) to 31.04, marking a decrease of 9.24.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 17.88. This value is below the healthy minimum of 20. It has decreased from 22.25 (Mar 23) to 17.88, marking a decrease of 4.37.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 68.96. This value is within the healthy range. It has increased from 59.72 (Mar 23) to 68.96, marking an increase of 9.24.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 82.12. This value exceeds the healthy maximum of 70. It has increased from 77.75 (Mar 23) to 82.12, marking an increase of 4.37.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 23.30. This value is within the healthy range. It has increased from 18.42 (Mar 23) to 23.30, marking an increase of 4.88.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 11.73. This value is within the healthy range. It has increased from 9.03 (Mar 23) to 11.73, marking an increase of 2.70.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 20,231.08. It has decreased from 21,055.11 (Mar 23) to 20,231.08, marking a decrease of 824.03.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 6.94. This value exceeds the healthy maximum of 3. It has decreased from 7.57 (Mar 23) to 6.94, marking a decrease of 0.63.
  • For EV / EBITDA (X), as of Mar 24, the value is 46.46. This value exceeds the healthy maximum of 15. It has decreased from 59.42 (Mar 23) to 46.46, marking a decrease of 12.96.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 6.97. This value exceeds the healthy maximum of 3. It has decreased from 7.59 (Mar 23) to 6.97, marking a decrease of 0.62.
  • For Retention Ratios (%), as of Mar 24, the value is 68.95. This value is within the healthy range. It has increased from 59.71 (Mar 23) to 68.95, marking an increase of 9.24.
  • For Price / BV (X), as of Mar 24, the value is 10.15. This value exceeds the healthy maximum of 3. It has decreased from 11.39 (Mar 23) to 10.15, marking a decrease of 1.24.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 6.97. This value exceeds the healthy maximum of 3. It has decreased from 7.59 (Mar 23) to 6.97, marking a decrease of 0.62.
  • For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Relaxo Footwears Ltd as of March 12, 2025 is: ₹428.45

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Relaxo Footwears Ltd is Overvalued by 3.07% compared to the current share price 442.00

Intrinsic Value of Relaxo Footwears Ltd as of March 12, 2025 is: 387.01

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Relaxo Footwears Ltd is Overvalued by 12.44% compared to the current share price 442.00

Last 5 Year EPS CAGR: -9.67%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 23.67%, which is a positive sign.
  2. The company has higher reserves (1,082.15 cr) compared to borrowings (183.00 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (76.92 cr) and profit (221.92 cr) over the years.
  1. The stock has a high average Working Capital Days of 47.92, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 115.83, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Relaxo Footwears Ltd:
    1. Net Profit Margin: 6.87%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 13.12% (Industry Average ROCE: 12.06%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 10.01% (Industry Average ROE: 9.82%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 11.73
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.25
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 62.7 (Industry average Stock P/E: 60.47)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.01
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Relaxo Footwears Ltd. is a Public Limited Listed company incorporated on 13/09/1984 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1984PLC019097 and registration number is 019097. Currently Company is involved in the business activities of Manufacture of footwear. Company's Total Operating Revenue is Rs. 2914.06 Cr. and Equity Capital is Rs. 24.89 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
FootwearsAggarwal City Square, Plot No. 10, Manglam Place, Delhi Delhi 110085rfl@relaxofootwear.com
http://www.relaxofootwear.com
Management
NamePosition Held
Mr. Ramesh Kumar DuaChairman & Managing Director
Mr. Mukand Lal DuaWhole Time Director
Mr. Nikhil DuaWhole Time Director
Mr. Gaurav DuaWhole Time Director
Mr. Sushil BatraExecutive Director & CFO
Ms. Deepa VermaIndependent Director
Mr. Kuldip Singh DhingraIndependent Director
Mr. Rajeev Rupendra BhadauriaIndependent Director
Mr. Yogesh KapurIndependent Director
Mr. Raj Kumar JainIndependent Director
Ms. Richa AroraIndependent Director

FAQ

What is the latest intrinsic value of Relaxo Footwears Ltd?

The latest intrinsic value of Relaxo Footwears Ltd as on 12 March 2025 is ₹428.45, which is 3.07% lower than the current market price of 442.00, indicating the stock is overvalued by 3.07%. The intrinsic value of Relaxo Footwears Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹10,999 Cr. and recorded a high/low of ₹950/408 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹1,986 Cr and total liabilities of ₹2,722 Cr.

What is the Market Cap of Relaxo Footwears Ltd?

The Market Cap of Relaxo Footwears Ltd is 10,999 Cr..

What is the current Stock Price of Relaxo Footwears Ltd as on 12 March 2025?

The current stock price of Relaxo Footwears Ltd as on 12 March 2025 is ₹442.

What is the High / Low of Relaxo Footwears Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Relaxo Footwears Ltd stocks is ₹950/408.

What is the Stock P/E of Relaxo Footwears Ltd?

The Stock P/E of Relaxo Footwears Ltd is 62.7.

What is the Book Value of Relaxo Footwears Ltd?

The Book Value of Relaxo Footwears Ltd is 80.8.

What is the Dividend Yield of Relaxo Footwears Ltd?

The Dividend Yield of Relaxo Footwears Ltd is 0.68 %.

What is the ROCE of Relaxo Footwears Ltd?

The ROCE of Relaxo Footwears Ltd is 13.9 %.

What is the ROE of Relaxo Footwears Ltd?

The ROE of Relaxo Footwears Ltd is 10.5 %.

What is the Face Value of Relaxo Footwears Ltd?

The Face Value of Relaxo Footwears Ltd is 1.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Relaxo Footwears Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE